The growing preference for home-based cancer treatment is reshaping patient care, with the Mayo Clinic’s recent study showing 73% of patients favoring it over traditional methods.
Story Snapshot
- A majority of cancer patients prefer home-based treatment over in-clinic care.
- The Mayo Clinic conducted the first U.S.-based randomized trial on this topic.
- Patients report reduced logistical, emotional, and financial burdens with home care.
- The study could influence future healthcare delivery models and policies.
The Shift to Home-Based Cancer Care
The Mayo Clinic’s Cancer Care Beyond Walls program marks a pivotal shift in cancer treatment delivery, offering patients the opportunity to receive chemotherapy and hormonal therapy in the comfort of their own homes. This approach responds to the logistical, emotional, and financial challenges often associated with traditional clinic visits. As healthcare systems evolve, the preference for home-based care reflects broader trends toward decentralization and patient-centered models, particularly for chronic and complex conditions.
This study, conducted over 24 weeks, involved participants receiving either in-home or in-clinic care, followed by an additional 16 weeks of home-based treatment for all. The trial’s results, published in 2025, show a striking 73% of patients favoring home-based treatment. High satisfaction scores were reported for both modalities, yet the logistical ease of home care made it more appealing to most participants.
Implications for Rural and Underserved Populations
The implications of this study are particularly significant for rural and underserved populations. These groups often face greater challenges in accessing regular cancer care due to travel distances and limited resources. By reducing the need for frequent clinic visits, home-based treatment can alleviate these burdens and improve patient access to necessary care. This model not only enhances convenience but also promotes a higher quality of life for patients who might otherwise struggle to maintain their treatment regimens.
While international studies have previously established the safety and feasibility of home-based chemotherapy, the Mayo Clinic’s trial is the first of its kind in the United States. The study’s findings are critical in validating the model’s efficacy within the U.S. context, addressing previous concerns about safety and monitoring that have traditionally confined cancer treatment to clinical settings.
Challenges and Considerations
Despite the positive reception, the transition to home-based cancer care is not without its challenges. Clinicians emphasize the necessity of robust safety protocols and clear patient selection criteria to ensure the effectiveness of at-home treatment. Furthermore, the small sample size and single-institution setting of the Mayo Clinic study suggest a need for larger, multi-center trials to confirm the findings and explore scalability.
Industry experts and patient advocates alike underscore the importance of offering choice and flexibility in care delivery. As the healthcare landscape continues to evolve, the potential for home-based cancer care to reduce costs and improve patient outcomes positions it as a viable option for the future. Continued research and development will be crucial in addressing existing barriers and expanding these services to a broader patient population.
Sources:
Home Health Care News, “73% Of Cancer Patients Prefer In-Home Treatment,” July 2025
